TABLE 4.
TC, mg/dL |
|||||||
<200 (n = 388)2 |
200–239 (n = 408) |
≥240 (n = 140) |
|||||
Lipid and time point | GTE (n = 199) | Placebo (n = 189) | GTE (n = 200) | Placebo (n = 208) | GTE (n = 64) | Placebo (n = 76) | P-interaction3 |
TC, mg/dL | 0.01 | ||||||
Baseline | 180 | 180 | 216 | 218 | 259 | 260 | |
Δ Month 6 | 0.44 | 4.18 | −9.43 | −1.54 | −19.88 | −9.46 | |
Δ Month 12 | 4.65 | 6.06 | −7.75 | 0.41 | −21.57 | −7.31 | |
P4 | 1.00 | <0.0001 | 0.0004 | ||||
HDL cholesterol, mg/dL | 0.19 | ||||||
Baseline | 65 | 64 | 74 | 72 | 75 | 75 | |
Δ Month 6 | 0.24 | 1.70 | −2.22 | −0.35 | −3.09 | 0.17 | |
Δ Month 12 | 1.72 | 1.27 | −1.59 | 0.41 | −1.20 | 0.89 | |
P4 | 1.00 | 0.083 | 0.37 | ||||
LDL cholesterol,5 mg/dL | 0.06 | ||||||
Baseline | 98 | 96 | 124 | 125 | 161 | 163 | |
Δ Month 6 | −0.40 | 2.99 | −7.82 | −0.71 | −15.23 | −8.93 | |
Δ Month 12 | 1.92 | 4.81 | −6.80 | 0.58 | −19.58 | −7.20 | |
P4 | 0.70 | <0.0001 | 0.006 | ||||
Triglycerides, mg/dL | 0.43 | ||||||
Baseline | 89 | 99 | 90 | 101 | 116 | 115 | |
Δ Month 6 | 3.14 | −2.39 | 3.07 | −2.26 | −7.99 | −0.86 | |
Δ Month 12 | 5.21 | 0.01 | 3.10 | −3.03 | −1.89 | −7.89 | |
P4 | 0.59 | 0.36 | 1.00 | ||||
TC:HDL-cholesterol ratio | 0.90 | ||||||
Baseline | 2.94 | 2.97 | 3.09 | 3.25 | 3.65 | 3.76 | |
Δ Month 6 | −0.02 | 0.005 | −0.07 | −0.03 | −0.16 | −0.14 | |
Δ Month 12 | −0.02 | 0.05 | −0.06 | −0.06 | −0.26 | −0.19 | |
P4 | 1.00 | 1.00 | 1.00 | ||||
Non-HDL cholesterol, mg/dL | 0.05 | ||||||
Baseline | 115 | 116 | 142 | 146 | 184 | 185 | |
Δ Month 6 | 0.20 | 2.48 | −7.21 | −1.18 | −16.79 | −9.63 | |
Δ Month 12 | 2.94 | 4.79 | −6.16 | −0.001 | −20.37 | −8.20 | |
P4 | 1.00 | 0.004 | 0.01 |
Values are least-squares means, Bonferroni-corrected, and adjusted for age and BMI at baseline. GTE, green tea extract; TC, total cholesterol; Δ, change.
n = 198 and 189 in the GTE and placebo groups, respectively, for the 12-mo time point.
P values for the interaction between treatment and baseline TC category were derived from a mixed-effects repeated-measures ANOVA with adjustment for age and BMI.
P values for the overall change in lipids from baseline to months 6 and 12 between the GTE and placebo groups were derived from a mixed-effects repeated-measures ANOVA with adjustment for age and BMI at baseline within each category of TC.
One subject was excluded due to missing values at baseline.